Furthermore, the IHC results demonstrated that Ki67 and PCNA levels were significantly reduced in tumors subjected to tRF-T36 mimic or taxol treatment, indicating that the tRF-T36 mimic effectively inhibits CRC progression (Fig. 6F). This evidence concerns the gene MKI67 and colorectal carcinoma.